Skip to main content

Table 3 Effects of plumbagin on (A) blood chemistry and (B) hematological parameters in serum of rats after daily oral administration at 25 mg/kg body weight for 28 days (3 males and 3 females for each group). Data are presented as median (interquartile range)

From: Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin

Parameter

Control

Plumbagin 25 mg/kg body weight

(A)

 Glucose (mg/dL)

248 (80)

230 (59)

 BUN (mg/dL)

20.5 (6.5)

22.0 (7.5)

 Creatinine (mg/dL)

0.50 (0.00)

0.50 (0.00)

 Cholesterol (mg/dL)

68 (3)

73 (6)

 Triglyceride (mg/dL)

106 (13)

110 (9)

 AST (U/L)

100 (17)

101 (15)

 ALT (U/L)

27 (10)

30 (11)

(B)

 RBC (×106/μL)

8.27 (0.50)

8.16 (0.72)

 Hemoglobin (g/dL)

14.9 (0.7)

14.4 (1.2)

 Hematocrit (%)

47.9 (3.0)

47.8 (2.6)

 WBC (×103/μL)

9.10 (0.80)

9.40 (0.65)

 Neutrophils (×103/μL)

1.92 (0.11)

2.20 (0.63)

 Eosinophils (×103/μL)

0.50 (1.00)

0.00 (1.00)

 Lymphocytes (×103/μL)

7.41 (0.28)

7.59 (0.31)

 Monocytes (×103/μL)

0.00 (1.00)

0.00 (1.00)

 Platelets count (×103/μL)

870.00 (191.25)

885.50 (73.75)

 Blood morphology

Normal

Normal